PHYLOGICA INVITED TO PRESENT AT INTERNATIONAL CONFERENCE Perth, Australia, 20 December 2006: Australian drug discovery company Phylogica’s innovative Phylomer® technology will be showcased internationally at the prestigious Peptalk Conference in San Diego, US next month.
Dr Paul Watt, Vice President Technology Development and Ms Rolee Kumar, Director of Business Development of Phylogica (ASX: PYC) are invited speakers at the 6th Annual Peptalk Conference (www.chi-PepTalk.com) to be held on 8-12 January 2007.
The Peptalk Conference is a high profile, invitation only event attended by an executive level audience of pharmaceutical and biotechnology companies, including Pfizer, AstraZeneca, Eli Lilly and Amgen. Recent interest in the protein/peptide drug discovery space has been seen through the acquisition of Domantis by GSK for US$453m and Avidia by Amgen for US$380m.
Phylogica has a leading position in peptide drug discovery with its unique Phylomer® technology. Ms Kumar’s presentation is focused on business development and potential partners attending the Peptalk conference.
The presentation is attached for reference and will be available for download in colour from Phylogica’s website (www.phylogica.com).
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)